Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen processing mutant cells to class i-restricted cell-mediated lysis

Karen Anderson, P. Cresswell, M. Gammon, J. Hermes, A. Williamson, H. Zweerink

Research output: Contribution to journalArticle

195 Citations (Scopus)

Abstract

The HLA-A2-positive human mutant cell line T2 is not lysed by influenza virus-specific HLA-A2-restricted cytotoxic lymphocytes after virus infection. However, lysis does occur when cells are incubated with the antigenic influenza matrix protein-derived peptide M57-68. To examine the nature of this defect, T2 cells were transfected with two different plasmids. One plasmid encoded the peptide M57-68, and the other encoded the same peptide preceded by an endoplasmic reticulum translocation signal sequence. Mutant T2 cells expressing the M57-68 peptide without the signal sequence were not susceptible to lysis by M57-68-specific HLA-A2-restricted cytotoxic T lymphocytes, whereas T2 cells expressing the M57-68 peptide plus signal sequence were lysed effectively. Lysis of parental T1 cells with either plasmid was equally effective. These results suggest that the T2 mutant cells are defective in the transport of antigenic peptides from the cytosol into the secretory pathway.

Original languageEnglish (US)
Pages (from-to)489-492
Number of pages4
JournalJournal of Experimental Medicine
Volume174
Issue number2
StatePublished - 1991
Externally publishedYes

Fingerprint

Antigen Presentation
Protein Sorting Signals
Endoplasmic Reticulum
HLA-A2 Antigen
Peptides
Plasmids
Secretory Pathway
Cytotoxic T-Lymphocytes
Virus Diseases
Orthomyxoviridae
Cytosol
Human Influenza
Lymphocytes
Cell Line
Proteins

ASJC Scopus subject areas

  • Immunology

Cite this

Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen processing mutant cells to class i-restricted cell-mediated lysis. / Anderson, Karen; Cresswell, P.; Gammon, M.; Hermes, J.; Williamson, A.; Zweerink, H.

In: Journal of Experimental Medicine, Vol. 174, No. 2, 1991, p. 489-492.

Research output: Contribution to journalArticle

@article{1d62dacf08ed44639ecd7de22bb4ec1f,
title = "Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen processing mutant cells to class i-restricted cell-mediated lysis",
abstract = "The HLA-A2-positive human mutant cell line T2 is not lysed by influenza virus-specific HLA-A2-restricted cytotoxic lymphocytes after virus infection. However, lysis does occur when cells are incubated with the antigenic influenza matrix protein-derived peptide M57-68. To examine the nature of this defect, T2 cells were transfected with two different plasmids. One plasmid encoded the peptide M57-68, and the other encoded the same peptide preceded by an endoplasmic reticulum translocation signal sequence. Mutant T2 cells expressing the M57-68 peptide without the signal sequence were not susceptible to lysis by M57-68-specific HLA-A2-restricted cytotoxic T lymphocytes, whereas T2 cells expressing the M57-68 peptide plus signal sequence were lysed effectively. Lysis of parental T1 cells with either plasmid was equally effective. These results suggest that the T2 mutant cells are defective in the transport of antigenic peptides from the cytosol into the secretory pathway.",
author = "Karen Anderson and P. Cresswell and M. Gammon and J. Hermes and A. Williamson and H. Zweerink",
year = "1991",
language = "English (US)",
volume = "174",
pages = "489--492",
journal = "Journal of Experimental Medicine",
issn = "0022-1007",
publisher = "Rockefeller University Press",
number = "2",

}

TY - JOUR

T1 - Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen processing mutant cells to class i-restricted cell-mediated lysis

AU - Anderson, Karen

AU - Cresswell, P.

AU - Gammon, M.

AU - Hermes, J.

AU - Williamson, A.

AU - Zweerink, H.

PY - 1991

Y1 - 1991

N2 - The HLA-A2-positive human mutant cell line T2 is not lysed by influenza virus-specific HLA-A2-restricted cytotoxic lymphocytes after virus infection. However, lysis does occur when cells are incubated with the antigenic influenza matrix protein-derived peptide M57-68. To examine the nature of this defect, T2 cells were transfected with two different plasmids. One plasmid encoded the peptide M57-68, and the other encoded the same peptide preceded by an endoplasmic reticulum translocation signal sequence. Mutant T2 cells expressing the M57-68 peptide without the signal sequence were not susceptible to lysis by M57-68-specific HLA-A2-restricted cytotoxic T lymphocytes, whereas T2 cells expressing the M57-68 peptide plus signal sequence were lysed effectively. Lysis of parental T1 cells with either plasmid was equally effective. These results suggest that the T2 mutant cells are defective in the transport of antigenic peptides from the cytosol into the secretory pathway.

AB - The HLA-A2-positive human mutant cell line T2 is not lysed by influenza virus-specific HLA-A2-restricted cytotoxic lymphocytes after virus infection. However, lysis does occur when cells are incubated with the antigenic influenza matrix protein-derived peptide M57-68. To examine the nature of this defect, T2 cells were transfected with two different plasmids. One plasmid encoded the peptide M57-68, and the other encoded the same peptide preceded by an endoplasmic reticulum translocation signal sequence. Mutant T2 cells expressing the M57-68 peptide without the signal sequence were not susceptible to lysis by M57-68-specific HLA-A2-restricted cytotoxic T lymphocytes, whereas T2 cells expressing the M57-68 peptide plus signal sequence were lysed effectively. Lysis of parental T1 cells with either plasmid was equally effective. These results suggest that the T2 mutant cells are defective in the transport of antigenic peptides from the cytosol into the secretory pathway.

UR - http://www.scopus.com/inward/record.url?scp=0025879780&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025879780&partnerID=8YFLogxK

M3 - Article

VL - 174

SP - 489

EP - 492

JO - Journal of Experimental Medicine

JF - Journal of Experimental Medicine

SN - 0022-1007

IS - 2

ER -